Featured Research

from universities, journals, and other organizations

First Step Towards Switching Off Breast Cancer And Leukaemia

Date:
August 11, 2008
Source:
Garvan Institute of Medical Research
Summary:
Scientists have identified a way to "switch off" a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia.

Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia.

Related Articles


The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.

A research team from the Garvan Institute of Medical Research, led by Professor Roger Daly, has found a novel way of blocking signals to and from Gab2, preventing it from fulfilling its role in cell proliferation. The finding is published online today in the EMBO Journal.

In 2002, Professor Daly identified the important role of Gab2 in breast cancer. His task since then has been to work out exactly how Gab2 functions, and how to stop it.

"Gab2 is a signalling protein, which means that it's involved in transmitting signals from the cell surface to the interior of the cell, instructing it to do specific things, such as divide or migrate" he said.

"Gab2 performs a number of signalling roles in normal cells throughout the body, and is usually switched off when it's not needed. Our task has been to work out how the body switches off Gab2, so that we can mimic that process in abnormal cells."

"We've identified a completely novel mechanism for switching off Gab2. This uses another molecule that attaches to Gab2 and acts as a kind of shield, preventing it from transmitting further proliferative signals."

"This binding partner, or 'off switch', is called 14-3-3, and is used to disable Gab2 in a number of cellular settings, when it is no longer needed."

"As Gab2 plays key roles in signalling systems that underpin both normal physiological responses and oncogenesis, it's very important to understand its control mechanisms."

"Our next step will be to obtain more structural information about how 14-3-3 shields Gab2. Once we know that, it should be possible to design drugs to combat Gab2-activated diseases in novel ways."


Story Source:

The above story is based on materials provided by Garvan Institute of Medical Research. Note: Materials may be edited for content and length.


Cite This Page:

Garvan Institute of Medical Research. "First Step Towards Switching Off Breast Cancer And Leukaemia." ScienceDaily. ScienceDaily, 11 August 2008. <www.sciencedaily.com/releases/2008/08/080808104919.htm>.
Garvan Institute of Medical Research. (2008, August 11). First Step Towards Switching Off Breast Cancer And Leukaemia. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2008/08/080808104919.htm
Garvan Institute of Medical Research. "First Step Towards Switching Off Breast Cancer And Leukaemia." ScienceDaily. www.sciencedaily.com/releases/2008/08/080808104919.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins